Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 5 (2008), Issue 6 (June)

1. NMO-IgG predicts the outcome of recurrent optic neuritis.
   Neurology, 70(23): 2197-200. [Abstract] [Full-text]
2. Adherence to the immunomodulatory drugs for multiple sclerosis: contrasting factors affect stopping drug and missing doses.
   Pharmacoepidemiol Drug Saf, 17(6): 565-76. [Abstract] [Full-text]
3. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis.
   Nat Med, 14(6): 688-93. [Abstract] [Full-text]
4. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis.
   Arch Neurol, 65(6): 812-6. [Abstract] [Full-text]
5. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis.
   Arch Neurol, 65(6): 809-11. [Abstract] [Full-text]
6. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up.
   Arch Neurol, 65(6): 727-32. [Abstract] [Full-text]
7. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
   J Nerv Ment Dis, 196(6): 492-5. [Abstract] [Full-text]
8. Seizures in multiple sclerosis.
   Epilepsia, 49(6): 948-53. [Abstract] [Full-text]
9. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
   Nat Rev Genet, 9(7): 516-26. [Abstract] [Full-text]
10. Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines.
    Proc Natl Acad Sci U S A, 105(24): 8381-6. [Abstract] [Full-text]
11. Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
    Lancet, 371(9630): 2085-92. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.